TITLE:
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

CONDITION:
Herpes Simplex

INTERVENTION:
Valacyclovir hydrochloride

SUMMARY:

      To determine the safety and efficacy of oral valacyclovir hydrochloride ( 256U87 ) compared
      to acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients with
      CD4 counts = or > 100 cells/mm3.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV infection with CD4 counts = or > 100 cells/mm3.

          -  Documented culture of anogenital herpes simplex virus (HSV) within the last 5 years.

          -  History of recurrent anogenital HSV infection, with a recurrence (with or without
             culture) within 1 year prior to study.

        Exclusion Criteria

        Co-existing Condition:

        Patients with the following symptoms and conditions are excluded:

          -  Malabsorption or vomiting that would potentially limit the retention and absorption
             of oral therapy.

        Concurrent Medication:

        Excluded:

          -  Systemic antiherpes medication.

          -  Interferon.

        Patients with the following prior conditions are excluded:

        History of hypersensitivity to acyclovir.
      
